Watch Ticker

Revolution Medicines, Inc. Common Stock

Go to Revolution Medicines, Inc. Common Stock Website

$38.34

1.16 (3.13%)

Live

Previous Close

$37.18

Day Range

$36.54 - $38.485

Previous Day Range

$36.2 - $37.26

Market Cap

$6.8 billion USD

Day Vol.

1.1 million

Previous Day Vol.

842415

Currency

USD

Primary Exchange

Nasdaq

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR si...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Tango Therapeutics - Tango Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of TNG462 plus Revolution Medicines’ Daraxonrasib or Zoldonrasib in Patients with RAS-Mutant MTAP-deleted Pancreatic or Lung Cancer

Tango Therapeutics initiated a Phase 1/2 clinical trial combining TNG462 with Revolution Medicines' daraxonrasib or zoldonrasib to treat RAS-mutant MTAP-deleted pancreatic and lung cancers, targeting potential new precision cancer therapies.

Related tickers: TNGX, RVMD, RVMDW.

Read Full Article

Globe Newswire - rEvolution Appoints Brian Gabriel as Vice President of Marketing Communications

rEvolution, a global leader in sports marketing, has appointed Brian Gabriel as its new Vice President of Marketing Communications. Gabriel brings over 16 years of experience in marketing leadership across sports, CPG, and entertainment sectors, and will be responsible for developing and executing integrated marketing and communications campaigns for rEvolution's clients.

Related tickers: RVMD, RVMDW, UP.

Read Full Article

Trending Tickers

Please sign in to view